Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ)
Gerard T. Vondeling, Julio Croda, Tomas Jelinek, George Kassianos et autres
3 citationsVaccine
George Kassianos
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
144Publications signalées
1839Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Vaccine Coverage and HesitancyInfluenza Virus Research StudiesHepatitis Viruses Studies and EpidemiologyTravel-related health issuesRespiratory viral infections research
Publications récentes
Expert opinion on improving influenza vaccination coverage rate in Qatar: Strategic solutions and role of live attenuated influenza vaccine (LAIV)
Muna Almaslamani, George Kassianos, Khalid El Awad, Eman Al Maslamani et autres
0 citationsHuman Vaccines & Immunotherapeutics
Infectious diseases, infection control, vaccines and long-term care: an European interdisciplinary Council on ageing consensus document
Nicola Veronese, Jane Barratt, Eveline Coemans, Pete Dayananda et autres
5 citationsAging Clinical and Experimental Research
Comparative effectiveness of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children over multiple influenza seasons (2019–2023)
Allyn Bandell, George Kassianos, Oliver Dibben, Georges El Azzi
4 citationsVaccine X
Why not a 95-95-95 strategy for influenza by 2030?
Filipe Froes, George Kassianos
0 citationsPulmonology
A plain language summary of responses to common misconceptions relating to updated COVID-19 mRNA vaccines
George Kassianos, Ivan Aloysius
0 citationsExpert Review of Vaccines
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment
Charles Reynard, James Campling, Adam Gordon, George Kassianos et autres
4 citationsExpert Review of Vaccines
Evolution and Impact of Hepatitis A Epidemiology in Europe—Systematic Literature Review of the Last 20 Years
Anar Andani, Kassiani Μellou, Pavitra Dewda, Jennifer Eeuwijk et autres
10 citationsJournal of Viral Hepatitis
Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024”
George Kassianos, Rok Čivljak, Gerrit A. van Essen, Oana Falup Pecurariu et autres
6 citationsGERMS
The influenza landscape and vaccination coverage in older adults during the SARS-Cov-2 pandemic: data from Several European Countries and Israel
George Kassianos, Jean‐Marie Cohen, Rok Čivljak, Nadav Davidovitch et autres
10 citationsExpert Review of Respiratory Medicine
Q&A April 2024 on the Influenza Immunisation Contract
0 citationsJournal of the British Global and Travel Health Association
Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines
George Kassianos, Pauline MacDonald, Ivan Aloysius, Shanti Pather
5 citationsVaccines
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.